Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG30005)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
LINC00336
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Unspecific Target [Unspecific Target]
In total 1 item(s) under this target | ||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | |||
Responsed Disease | Lung cancer | ICD-11: 2C25 | ||
Pathway Response | Ferroptosis | hsa04216 | ||
Cell Process | Cell ferroptosis | |||
Cell proliferation | ||||
In Vitro Model |
NCI-H358 cells | Minimally invasive lung adenocarcinoma | Homo sapiens | CVCL_1559 |
PC-9 cells | Lung adenocarcinoma | Homo sapiens | CVCL_B260 | |
A-549 cells | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | |
SPC-A1 cells | Endocervical adenocarcinoma | Homo sapiens | CVCL_6955 | |
Response regulation | LSH induces ELAVL1 expression through the inactivation of p53 and ELAVL1 enhances LINC00336 levels through transcriptional regulation by interacting with LINC00336. Then, LINC00336 absorbs MIR6852 as a ceRNA, which increases the mRNA level of CBS, stimulating cell proliferation, colony formation, and tumor formation, and inhibiting ferroptosis in lung cancer. | |||
Lung cancer [ICD-11: 2C25]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | |||
Target Regulator | LINC00336 (IncRNA) | lncRNA | ||
Pathway Response | Ferroptosis | hsa04216 | ||
Cell Process | Cell ferroptosis | |||
Cell proliferation | ||||
In Vitro Model |
NCI-H358 cells | Minimally invasive lung adenocarcinoma | Homo sapiens | CVCL_1559 |
PC-9 cells | Lung adenocarcinoma | Homo sapiens | CVCL_B260 | |
A-549 cells | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | |
SPC-A1 cells | Endocervical adenocarcinoma | Homo sapiens | CVCL_6955 | |
Response regulation | LSH induces ELAVL1 expression through the inactivation of p53 and ELAVL1 enhances LINC00336 levels through transcriptional regulation by interacting with LINC00336. Then, LINC00336 absorbs MIR6852 as a ceRNA, which increases the mRNA level of CBS, stimulating cell proliferation, colony formation, and tumor formation, and inhibiting ferroptosis in lung cancer. | |||